Related Experiment Video
Updated: Apr 30, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal microbial therapy: promises and pitfalls
Daniel Merenstein1, Najwa El-Nachef, Susan V Lynch
1*Department of Family Medicine, Georgetown University Medical Center, Washington, DC †Division of Gastroenterology, Department of Medicine, University of California, San Francisco.
Abstract:
A rapidly expanding range of diverse human diseases is now associated with perturbations to the gastrointestinal microbiome. Fecal microbial transplant (FMT) has been used with high rates of efficacy to treat gastrointestinal microbiome perturbation associated with recurrent Clostridium difficile infection, and is now being considered for other indications. Here we discuss the gut microbiome, review published and ongoing studies using FMT as a treatment modality for human disease, consider the regulatory aspects of FMT, and outline some factors that should be considered in patients in whom this therapeutic strategy is being contemplated.
Insights
Fecal microbial transplants (FMT) show high efficacy for recurrent C. difficile infection and are being explored for other diseases. This review covers the gut microbiome, FMT studies, and considerations for patient treatment.
Area of Science:
- Gastroenterology and Microbiology
- Human Disease Research
Background:
- The gastrointestinal microbiome plays a crucial role in human health.
- Alterations in the gut microbiome are linked to a growing number of diverse human diseases.
Purpose of the Study:
- To discuss the gut microbiome and its relation to human diseases.
- To review current and ongoing studies on Fecal Microbial Transplant (FMT) as a therapeutic strategy.
- To consider regulatory aspects and patient factors for FMT implementation.
Main Methods:
- Literature review of published studies on FMT.
- Analysis of ongoing clinical trials involving FMT.
- Discussion of regulatory frameworks and clinical considerations for FMT.
Main Results:
- Fecal Microbial Transplant (FMT) demonstrates high efficacy in treating recurrent Clostridium difficile infection.
- FMT is being investigated for a wider range of human diseases linked to microbiome dysbiosis.
Conclusions:
- FMT is a promising therapeutic option for specific microbiome-related disorders.
- Further research and careful patient selection are essential for expanding FMT applications.
- Regulatory oversight is critical for the safe and effective use of FMT.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Introduction to the Human Microbiota
Probiotics
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Functions of the Gut Microbiota
Development of Human Microbiota

